MA
Muraleedharan Ajithkumar
About Muraleedharan Ajithkumar
Muraleedharan Ajithkumar has 14 years in corporate governance. Holds Director role. Currently with 3 companies, including Esente Healthcare Private Limited and Ionxsystems Private Limited. Formerly with 1 company, such as Jubilant Draximage Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Esente Healthcare Private Limited
U24230KA2014PTC077890
|
Director | 21 Sep 2020 | 2014 | Active |
Ionxsystems Private Limited
U46596DL2025PTC456396
|
Director | 06 Oct 2025 | 2025 | Active |
Esente Innovations & Research Solutions Private Limited
U21000KA2023PTC182885
|
Director | 29 Dec 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Jubilant Draximage Limited
U74900UP2009FLC038194
|
Whole-Time Director | 01 Jun 2012 | 2009 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Muraleedharan Ajithkumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Muraleedharan Ajithkumar
Muraleedharan Ajithkumar has 14 years in corporate governance. Holds Director role. Currently with 3 companies, including Esente Healthcare Private Limited and Ionxsystems Private Limited. Formerly with 1 company, such as Jubilant Draximage Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Muraleedharan Ajithkumar is associated with 3 companies as Director.
Muraleedharan Ajithkumar has expertise in Healthcare, General Business.
Muraleedharan Ajithkumar has 14 years in corporate governance.